UK Assesses Firms’ Coronavirus Resilience

More Funding Allotted To Vaccine And Diagnostic Research

With the coronavirus outbreak gathering pace around the world, the UK is taking steps to assess companies’ ability to deal with potential medicine supply shortages, and has made additional funding available for vaccine and diagnostic research. Yet more funding to help the UK tackle the outbreak has just been announced in the 11 March budget.

UK
The UK wants to hear about pharma firms' supply chains amid COVID-19 outbreak • Source: Shutterstock

More from United Kingdom

More from Europe